FDA Inspection 1176638 — Lonza Bend Inc.

Lonza Bend Inc. — FEI 1000656789

The FDA completed an inspection of Lonza Bend Inc. on August 5, 2022 in Bend, OR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 5, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bend, OR (United States)

Citations

IDCFRDescription
191221 CFR 211.166(a)Written program not followed
360321 CFR 211.160(b)Scientifically sound laboratory controls
440221 CFR 211.192Written record of investigation incomplete